Platelet Rich Plasma (PRP) - Global Market Outlook (2017-2023)

  • ID: 4426227
  • Report
  • Region: Global
  • 173 pages
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Cesc
  • DePuy Synthes
  • EmCyte Corporation
  • Glofinn
  • Regen Lab SA
  • Stryker Corporation
  • MORE
The Global Platelet Rich Plasma (PRP) market is estimated at $158.23 million in 2016 and is expected to reach $383.56 million by 2023 growing at a CAGR of 13.4% from 2016 to 2023. Increasing number of patients suffering from orthopedic injuries, growing occurrence of neurological and cardiothoracic disorders, technological advancements, regulatory approvals for new devices and increasing application in cosmetic surgery are some of the key factors influencing the market. However, high cost of medical devices and difficulty in quality control of test results and standardization in quality of allergen extracts are some main factors restraining the market growth.

By Type, leukocyte-platelet rich plasma (L-PRP) segment acquired the largest market share during the forecast period. The growth for this segment is due to the existence of inductive properties that help in stimulation of healing processes and it is anticipated to continue its dominance for the next few years. Amongst Type, orthopedic and spinal surgery segment commanded the largest market share due to the large number of orthopedic and sports injuries such as rotator cuff, hamstring, tendon injuries and tennis elbow. North America held the largest market share during the forecast period. The rising prevalence of orthopedic diseases and sports injuries, coupled with the availability of enhanced diagnostics and sophisticated healthcare facilities augmented the demand for PRP from North America.

Some of the key players in the market include Zimmer Biomet, Inc, YCellBio, Stryker Corporation, RM Bio, Regen Lab SA, Medira, Harvest Technologies Corp., Glofinn, Exatech, Inc., EmCyte Corporation, DR. PRP America, DePuy Synthes, Cytomedix, Cesca Therapeutics, CellMedix, Arthrex, Inc., Arteriocyte Medical Systems, Inc. and AdiStem, Ltd.

Origins Covered:
  • Homologous
  • Allogeneic
  • Autologous
Products Covered:
  • Leukocyte-Platelet Rich Plasma (L-PRP)
  • Leukocyte-Platelet Rich Fibrin (L-PRF)
  • Pure-Platelet Rich Plasma (P-PRP)
Applications Covered:
  • Cosmetic Surgery and Aesthetics
  • General Surgery
  • Neurosurgery
  • Orthopedic and Spinal Surgery
  • Other Clinical Applications
  • Urology
  • Cardiothoracic Surgery
  • Oral and Maxillofacial Surgery
  • Periodontal Surgery
  • Otorhinolaryngology-Head and Neck Surgery
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cesc
  • DePuy Synthes
  • EmCyte Corporation
  • Glofinn
  • Regen Lab SA
  • Stryker Corporation
  • MORE
1. Executive Summary

2. Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3. Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4. Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5. Global Platelet Rich Plasma (PRP) Market, By Origin
5.1 Introduction
5.2 Homologous
5.3 Allogeneic
5.4 Autologous

6. Global Platelet Rich Plasma (PRP) Market, By Product
6.1 Introduction
6.2 Leukocyte-Platelet Rich Plasma (L-PRP)
6.3 Leukocyte-Platelet Rich Fibrin (L-PRF)
6.4 Pure-Platelet Rich Plasma (P-PRP)

7. Global Platelet Rich Plasma (PRP) Market, By Application
7.1 Introduction
7.2 Cosmetic Surgery and Aesthetics
7.3 General Surgery
7.4 Neurosurgery
7.5 Orthopedic and Spinal Surgery
7.6 Other Applications
7.6.1 Urology
7.6.2 Cardiothoracic Surgery
7.6.3 Oral and Maxillofacial Surgery
7.6.4 Periodontal Surgery
7.6.5 Otorhinolaryngology-Head and Neck Surgery

8. Global Platelet Rich Plasma (PRP) Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9. Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10. Company Profiling
10.1 Zimmer Biomet, Inc
10.2 YCellBio
10.3 Stryker Corporation
10.4 RM Bio
10.5 Regen Lab SA
10.6 Medira
10.7 Harvest Technologies Corp.
10.8 Glofinn
10.9 Exatech, Inc.
10.10 EmCyte Corporation
10.11 DR. PRP America
10.12 DePuy Synthes
10.13 Cytomedix
10.14 Cesca Therapeutics
10.15 CellMedix
10.16 Arthrex, Inc.
10.17 Arteriocyte Medical Systems, Inc.
10.18 AdiStem, Ltd.

List of Tables

Table 1 Global Platelet Rich Plasma (PRP) Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Platelet Rich Plasma (PRP) Market Outlook, By Origin (2014-2023) ($MN)
Table 3 Global Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2014-2023) ($MN)
Table 4 Global Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2014-2023) ($MN)
Table 5 Global Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2014-2023) ($MN)
Table 6 Global Platelet Rich Plasma (PRP) Market Outlook, By Product (2014-2023) ($MN)
Table 7 Global Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Plasma (L-PRP) (2014-2023) ($MN)
Table 8 Global Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Fibrin (L-PRF) (2014-2023) ($MN)
Table 9 Global Platelet Rich Plasma (PRP) Market Outlook, By Pure-Platelet Rich Plasma (P-PRP) (2014-2023) ($MN)
Table 10 Global Platelet Rich Plasma (PRP) Market Outlook, By Application (2014-2023) ($MN)
Table 11 Global Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic Surgery and Aesthetics (2014-2023) ($MN)
Table 12 Global Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2014-2023) ($MN)
Table 13 Global Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2014-2023) ($MN)
Table 14 Global Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2014-2023) ($MN)
Table 15 Global Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2014-2023) ($MN)
Table 16 Global Platelet Rich Plasma (PRP) Market Outlook, By Urology (2014-2023) ($MN)
Table 17 Global Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2014-2023) ($MN)
Table 18 Global Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2014-2023) ($MN)
Table 19 Global Platelet Rich Plasma (PRP) Market Outlook, By Periodontal Surgery (2014-2023) ($MN)
Table 20 Global Platelet Rich Plasma (PRP) Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2014-2023) ($MN)
Table 21 North America Platelet Rich Plasma (PRP) Market Outlook, By Country (2014-2023) ($MN)
Table 22 North America Platelet Rich Plasma (PRP) Market Outlook, By Origin (2014-2023) ($MN)
Table 23 North America Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2014-2023) ($MN)
Table 24 North America Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2014-2023) ($MN)
Table 25 North America Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2014-2023) ($MN)
Table 26 North America Platelet Rich Plasma (PRP) Market Outlook, By Product (2014-2023) ($MN)
Table 27 North America Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Plasma (L-PRP) (2014-2023) ($MN)
Table 28 North America Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Fibrin (L-PRF) (2014-2023) ($MN)
Table 29 North America Platelet Rich Plasma (PRP) Market Outlook, By Pure-Platelet Rich Plasma (P-PRP) (2014-2023) ($MN)
Table 30 North America Platelet Rich Plasma (PRP) Market Outlook, By Application (2014-2023) ($MN)
Table 31 North America Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic Surgery and Aesthetics (2014-2023) ($MN)
Table 32 North America Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2014-2023) ($MN)
Table 33 North America Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2014-2023) ($MN)
Table 34 North America Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2014-2023) ($MN)
Table 35 North America Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2014-2023) ($MN)
Table 36 North America Platelet Rich Plasma (PRP) Market Outlook, By Urology (2014-2023) ($MN)
Table 37 North America Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2014-2023) ($MN)
Table 38 North America Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2014-2023) ($MN)
Table 39 North America Platelet Rich Plasma (PRP) Market Outlook, By Periodontal Surgery (2014-2023) ($MN)
Table 40 North America Platelet Rich Plasma (PRP) Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2014-2023) ($MN)
Table 41 Europe Platelet Rich Plasma (PRP) Market Outlook, By Country (2014-2023) ($MN)
Table 42 Europe Platelet Rich Plasma (PRP) Market Outlook, By Origin (2014-2023) ($MN)
Table 43 Europe Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2014-2023) ($MN)
Table 44 Europe Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2014-2023) ($MN)
Table 45 Europe Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2014-2023) ($MN)
Table 46 Europe Platelet Rich Plasma (PRP) Market Outlook, By Product (2014-2023) ($MN)
Table 47 Europe Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Plasma (L-PRP) (2014-2023) ($MN)
Table 48 Europe Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Fibrin (L-PRF) (2014-2023) ($MN)
Table 49 Europe Platelet Rich Plasma (PRP) Market Outlook, By Pure-Platelet Rich Plasma (P-PRP) (2014-2023) ($MN)
Table 50 Europe Platelet Rich Plasma (PRP) Market Outlook, By Application (2014-2023) ($MN)
Table 51 Europe Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic Surgery and Aesthetics (2014-2023) ($MN)
Table 52 Europe Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2014-2023) ($MN)
Table 53 Europe Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2014-2023) ($MN)
Table 54 Europe Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2014-2023) ($MN)
Table 55 Europe Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2014-2023) ($MN)
Table 56 Europe Platelet Rich Plasma (PRP) Market Outlook, By Urology (2014-2023) ($MN)
Table 57 Europe Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2014-2023) ($MN)
Table 58 Europe Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2014-2023) ($MN)
Table 59 Europe Platelet Rich Plasma (PRP) Market Outlook, By Periodontal Surgery (2014-2023) ($MN)
Table 60 Europe Platelet Rich Plasma (PRP) Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2014-2023) ($MN)
Table 61 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Country (2014-2023) ($MN)
Table 62 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Origin (2014-2023) ($MN)
Table 63 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2014-2023) ($MN)
Table 64 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2014-2023) ($MN)
Table 65 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2014-2023) ($MN)
Table 66 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Product (2014-2023) ($MN)
Table 67 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Plasma (L-PRP) (2014-2023) ($MN)
Table 68 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Fibrin (L-PRF) (2014-2023) ($MN)
Table 69 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Pure-Platelet Rich Plasma (P-PRP) (2014-2023) ($MN)
Table 70 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Application (2014-2023) ($MN)
Table 71 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic Surgery and Aesthetics (2014-2023) ($MN)
Table 72 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2014-2023) ($MN)
Table 73 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2014-2023) ($MN)
Table 74 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2014-2023) ($MN)
Table 75 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2014-2023) ($MN)
Table 76 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Urology (2014-2023) ($MN)
Table 77 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2014-2023) ($MN)
Table 78 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2014-2023) ($MN)
Table 79 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Periodontal Surgery (2014-2023) ($MN)
Table 80 Asia pacific Platelet Rich Plasma (PRP) Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2014-2023) ($MN)
Table 81 South America Platelet Rich Plasma (PRP) Market Outlook, By Country (2014-2023) ($MN)
Table 82 South America Platelet Rich Plasma (PRP) Market Outlook, By Origin (2014-2023) ($MN)
Table 83 South America Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2014-2023) ($MN)
Table 84 South America Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2014-2023) ($MN)
Table 85 South America Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2014-2023) ($MN)
Table 86 South America Platelet Rich Plasma (PRP) Market Outlook, By Product (2014-2023) ($MN)
Table 87 South America Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Plasma (L-PRP) (2014-2023) ($MN)
Table 88 South America Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Fibrin (L-PRF) (2014-2023) ($MN)
Table 89 South America Platelet Rich Plasma (PRP) Market Outlook, By Pure-Platelet Rich Plasma (P-PRP) (2014-2023) ($MN)
Table 90 South America Platelet Rich Plasma (PRP) Market Outlook, By Application (2014-2023) ($MN)
Table 91 South America Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic Surgery and Aesthetics (2014-2023) ($MN)
Table 92 South America Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2014-2023) ($MN)
Table 93 South America Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2014-2023) ($MN)
Table 94 South America Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2014-2023) ($MN)
Table 95 South America Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2014-2023) ($MN)
Table 96 South America Platelet Rich Plasma (PRP) Market Outlook, By Urology (2014-2023) ($MN)
Table 97 South America Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2014-2023) ($MN)
Table 98 South America Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2014-2023) ($MN)
Table 99 South America Platelet Rich Plasma (PRP) Market Outlook, By Periodontal Surgery (2014-2023) ($MN)
Table 100 South America Platelet Rich Plasma (PRP) Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2014-2023) ($MN)
Table 101 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Country (2014-2023) ($MN)
Table 102 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Origin (2014-2023) ($MN)
Table 103 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2014-2023) ($MN)
Table 104 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2014-2023) ($MN)
Table 105 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2014-2023) ($MN)
Table 106 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Product (2014-2023) ($MN)
Table 107 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Plasma (L-PRP) (2014-2023) ($MN)
Table 108 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Platelet Rich Fibrin (L-PRF) (2014-2023) ($MN)
Table 109 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Pure-Platelet Rich Plasma (P-PRP) (2014-2023) ($MN)
Table 110 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Application (2014-2023) ($MN)
Table 111 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic Surgery and Aesthetics (2014-2023) ($MN)
Table 112 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2014-2023) ($MN)
Table 113 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2014-2023) ($MN)
Table 114 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2014-2023) ($MN)
Table 115 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2014-2023) ($MN)
Table 116 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Urology (2014-2023) ($MN)
Table 117 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2014-2023) ($MN)
Table 118 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2014-2023) ($MN)
Table 119 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Periodontal Surgery (2014-2023) ($MN)
Table 120 Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook, By Otorhinolaryngology-Head and Neck Surgery (2014-2023) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Zimmer Biomet, Inc
  • YCellBio
  • Stryker Corporation
  • RM Bio
  • Regen Lab SA
  • Medira
  • Harvest Technologies Corp.
  • Glofinn
  • Exatech, Inc.
  • EmCyte Corporation
  • DR. PRP America
  • DePuy Synthes
  • Cytomedix
  • Cesc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll